[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 66, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 536431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Rychlik", "age": 67, "title": "VP, Corporate Controller & Principal Financial Officer", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 302351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mina  Pastagia M.D., MS", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 463754, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "title": "Senior Vice President of Business & Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "maxAge": 86400, "priceHint": 4, "previousClose": 3.0912, "open": 3.11, "dayLow": 3.0011, "dayHigh": 3.3614, "regularMarketPreviousClose": 3.0912, "regularMarketOpen": 3.11, "regularMarketDayLow": 3.0011, "regularMarketDayHigh": 3.3614, "forwardPE": -2.469231, "volume": 8787, "regularMarketVolume": 8787, "averageVolume": 16155, "averageVolume10days": 15450, "averageDailyVolume10Day": 15450, "bidSize": 1000, "askSize": 800, "marketCap": 116056264, "fiftyTwoWeekLow": 1.07, "fiftyTwoWeekHigh": 5.26, "priceToSalesTrailing12Months": 24.698076, "fiftyDayAverage": 3.2734, "twoHundredDayAverage": 3.033, "currency": "USD", "enterpriseValue": 141845184, "floatShares": 10713585, "sharesOutstanding": 36154600, "sharesShort": 10682, "sharesShortPriorMonth": 14148, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.70334, "heldPercentInstitutions": 0.03914, "shortRatio": 0.78, "shortPercentOfFloat": 0.001, "impliedSharesOutstanding": 36154600, "bookValue": -1.564, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -79576000, "trailingEps": -2.2, "forwardEps": -1.3, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 30.186, "enterpriseToEbitda": -3.664, "52WeekChange": 1.3093526, "SandP52WeekChange": 0.2704494, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "ARMP", "underlyingSymbol": "ARMP", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 769440600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e9006f47-0d3e-3b07-8861-14c121fcb2a4", "messageBoardId": "finmb_84546611", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.21, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "totalCash": 37860000, "totalCashPerShare": 1.048, "ebitda": -38713000, "totalDebt": 63744000, "quickRatio": 0.36, "currentRatio": 0.379, "totalRevenue": 4699000, "revenuePerShare": 0.13, "returnOnAssets": -0.21697001, "freeCashflow": 81730752, "operatingCashflow": -40437000, "revenueGrowth": 0.214, "operatingMargins": -10.58799, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-14"}]